July 10, 2024
On July 9, the US Food and Drug Administration approved the supplemental new drug application for roflumilast cream 0.15% for the treatment of mild to moderate […]
July 10, 2024
TOPLINE: Over 5 years, dupilumab demonstrated acceptable safety and sustained efficacy, with significant improvements in the signs and symptoms of AD, in the treatment of moderate […]
July 10, 2024
TOPLINE: CCN3, a hormone secreted by neurons in the brain, enhances the density and strength of bone in lactating mice. This discovery could lead to new […]
July 10, 2024
TOPLINE: Spironolactone may benefit women of childbearing age with mild hidradenitis suppurativa (HS), especially if initiated early, according to the results of a single center retrospective […]
July 10, 2024
The latest study of the effects of the soft drinks industry levy (SDIL), introduced in 2018 and popularly known as the ‘sugar tax’, showed it was […]
July 10, 2024
Past Meetings, Conferences, & Workshops View FDA Archive for past meetings and materials: 2014-2016, 2017-2018 Stay Informed Upcoming Meetings Domestic and Virtual link to content hidden […]
July 10, 2024
On This Page Date: October 28 – 30, 2024 Day1: Mon, Oct 28 9:00 AM – 6:00 PM ET Day2: Tue, Oct 29 8:00 AM – […]
July 10, 2024
TOPLINE: Dupilumab treatment significantly improved both hair regrowth and the severity of atopic dermatitis (AD) in pediatric patients who also had alopecia areata (AA) in a […]
July 10, 2024
TOPLINE: Universal eye screening in newborns identifies retinal hemorrhage in 10.64% of babies and other ocular abnormalities in 7.5% of infants, with potential risk factors including […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623
Next page